Abbott Laboratories (ABT) vs Stryker (SYK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Stryker (SYK) has outperformed Abbott Laboratories (ABT) over the past year, losing 25.4% versus a loss of 26.6%. Over five years, SYK leads with a +3.4% price change compared with -16.2% for ABT. Abbott Laboratories is the larger company by market cap ($170.43 billion vs $106.24 billion), about 1.6 times the size, while Stryker is growing revenue faster (+11.2% vs +5.7%).
On valuation, Abbott Laboratories trades at a lower forward P/E (16.2x vs 16.6x for Stryker). Abbott Laboratories offers the higher dividend yield (2.52% vs 1.26%). Abbott Laboratories converts more of its revenue into profit, with a net margin of 14.7% versus 12.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABT | SYK |
|---|---|---|
| Share price | $98.49 | $276.97 |
| Market cap | $170.43B | $106.24B |
| 1-day change | -0.24% | +0.57% |
| YTD return | -21.39% | -21.64% |
| 1-year return | -26.65% | -25.41% |
| 5-year return | -16.17% | +3.41% |
| P/E ratio (TTM) | 31.87 | 28.70 |
| Forward P/E | 16.24 | 16.59 |
| EPS (TTM) | $3.09 | $9.65 |
| Dividend yield | 2.52% | 1.26% |
| Annual dividend | $2.48 | $3.48 |
| Revenue (latest FY) | $44.33B | $25.12B |
| Revenue growth (YoY) | +5.67% | +11.16% |
| Net income (latest FY) | $6.52B | $3.25B |
| Gross margin | 56.42% | 63.96% |
| Operating margin | 18.17% | 19.47% |
| Net margin | 14.72% | 12.92% |
| 52-week high | $134.50 | $392.55 |
| 52-week low | $81.97 | $267.00 |
| Distance from 52-week high | -26.77% | -29.44% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +22.57% | +32.20% |
| Average volume | 9.64M | 2.64M |
| Shares outstanding | 1.73B | 383.57M |
| Employees | 122,000 | 56,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Abbott Laboratories offers a meaningfully higher dividend yield (2.52% vs 1.26%).
- Stryker grew revenue faster in its latest fiscal year (+11.16% vs +5.67%).
About Abbott Laboratories
ABT stock →Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Health Care · Biotechnology: Pharmaceutical Preparations · 122,000 employees
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
ABT vs SYK FAQ
Which is bigger, Abbott Laboratories or Stryker?
Abbott Laboratories (ABT) is larger, with a market capitalization of $170.43B compared with $106.24B for Stryker (SYK).
Which stock has performed better over the past year, ABT or SYK?
SYK returned -25.41% over the past 12 months, compared with -26.65% for ABT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ABT or SYK?
SYK has the lower trailing P/E at 28.7, versus 31.9 for ABT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Abbott Laboratories or Stryker?
Abbott Laboratories has the higher yield at 2.52%, compared with 1.26% for Stryker.
Are Abbott Laboratories and Stryker in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Abbott Laboratories and Medical/Dental Instruments for Stryker.